Syndevrx

Cambridge, United States

SynDevRx develops polymer-based drug conjugates for small molecule drug activity.

$29.4M raised

Oct 2024

Venture - Series Unknown

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Syndevrx

How much funding has Syndevrx raised?

Syndevrx has raised $29.4M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in October 2024.

Where is Syndevrx headquartered?

Syndevrx is headquartered in Cambridge, United States.

What does Syndevrx do?

SynDevRx develops polymer-based drug conjugates for small molecule drug activity.

What stage is Syndevrx at?

Syndevrx is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 10, 2024.

MLA

"Syndevrx — Funding & Investors." VCBacked, October 10, 2024, https://www.vcbacked.co/company/syndevrx. Accessed June 3, 2026.

APA

VCBacked. (2024). Syndevrx — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/syndevrx

Wikipedia (cite web)

{{cite web |title=Syndevrx — Funding & Investors |url=https://www.vcbacked.co/company/syndevrx |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 10, 2024.